ID: ALA4746439

Max Phase: Preclinical

Molecular Formula: C7H7F2NO2

Molecular Weight: 175.13

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  N[C@H]1C=C(C(=O)O)CC1=C(F)F

Standard InChI:  InChI=1S/C7H7F2NO2/c8-6(9)4-1-3(7(11)12)2-5(4)10/h2,5H,1,10H2,(H,11,12)/t5-/m0/s1

Standard InChI Key:  FBLNZOCTNRXJQD-YFKPBYRVSA-N

Associated Targets(non-human)

Gamma-amino-N-butyrate transaminase 192 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 175.13Molecular Weight (Monoisotopic): 175.0445AlogP: 0.88#Rotatable Bonds: 1
Polar Surface Area: 63.32Molecular Species: ZWITTERIONHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.48CX Basic pKa: 9.16CX LogP: -2.03CX LogD: -2.04
Aromatic Rings: 0Heavy Atoms: 12QED Weighted: 0.62Np Likeness Score: 0.98

References

1. Shen S,Doubleday PF,Weerawarna PM,Zhu W,Kelleher NL,Silverman RB.  (2020)  Mechanism-Based Design of 3-Amino-4-Halocyclopentenecarboxylic Acids as Inactivators of GABA Aminotransferase.,  11  (10): [PMID:33062178] [10.1021/acsmedchemlett.9b00672]

Source